Radiology, Vol 205, 197-201, Copyright © 1997 by Radiological Society of North America

ARTICLES

Hippocampal transverse relaxation times in patients with Alzheimer disease

NG Campeau, RC Petersen, JP Felmlee, PC O'Brien and CR Jack Jr
Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905, USA.

PURPOSE: To determine whether hippocampal relaxation times in magnetic resonance (MR) imaging differ between patients with probable Alzheimer disease and elderly control subjects with normal cognition. MATERIALS AND METHODS: MR imaging relaxation times were measured in the head and body of the right and left hippocampi in 123 subjects: 62 patients with Alzheimer disease (44 women, 18 men; age range, 65-89 years) and 61 elderly control subjects without cognitive impairment (39 women, 22 men; age range, 65-89 years). Hippocampal relaxation times were correlated with clinical status (patient vs control subject), age, sex, laterality (right vs left), and location within the hippocampus (body vs head). The hippocampal T2 value was correlated with the severity of disease in the patients. RESULTS: No statistically significant difference in the relaxation times was found between the two clinical groups for the analysis of the right versus left hippocampi and the hippocampal head versus body. In both patients and control subjects, no correlation was found between T2 measurements and age or sex. Twenty- seven patients had a clinical dementia rating (CDR) score of 0.5 (very mild dementia), 21 patients had a CDR score of 1.0 (mild dementia), and eight patients had a CDR score of 2.0 (moderate dementia). The CDR score was not available in six patients. No statistically significant association between T2 values and severity of disease was observed. CONCLUSION: MR relaxation time measurements in the hippocampus are not useful for the detection of Alzheimer disease.

This article has been cited by other articles:

				B. H. Ridha, D. J. Tozer, M. R. Symms, K. C. Stockton, E. B. Lewis, M. M. Siddique, D. G. MacManus, M. N. Rossor, N. C. Fox, and P. S. Tofts Quantitative Magnetization Transfer Imaging in Alzheimer Disease Radiology, September 1, 2007; 244(3): 832 - 837. [Abstract] [Full Text] [PDF]

				A. Ramani, J. H. Jensen, and J. A. Helpern Quantitative MR Imaging in Alzheimer Disease Radiology, October 1, 2006; 241(1): 26 - 44. [Abstract] [Full Text] [PDF]

				M.J. House, T.G. St. Pierre, J.K. Foster, R.N. Martins, and R. Clarnette Quantitative MR Imaging R2 Relaxometry in Elderly Participants Reporting Memory Loss. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 430 - 439. [Abstract] [Full Text] [PDF]

				C. R. Jack Jr., D. W. Dickson, J. E. Parisi, Y. C. Xu, R. H. Cha, P. C. O'Brien, S. D. Edland, G. E. Smith, B. F. Boeve, E. G. Tangalos, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia Neurology, March 12, 2002; 58(5): 750 - 757. [Abstract] [Full Text] [PDF]

				H. Hanyu, T. Asano, T. Iwamoto, M. Takasaki, H. Shindo, and K. Abe Magnetization Transfer Measurements of the Hippocampus in Patients with Alzheimer's Disease, Vascular Dementia, and Other Types of Dementia AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1235 - 1242. [Abstract] [Full Text] [PDF]

				E. Neri, D. Caramella, F. Falaschi, P. Sbragia, C. Vignali, E. Laiolo, A. Viviani, and C. Bartolozzi Virtual CT Intravascular Endoscopy of the Aorta: Pierced Surface and Floating Shape Thresholding Artifacts Radiology, July 1, 1999; 212(1): 276 - 279. [Abstract] [Full Text]